• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Covaxin

DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group
DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group

The Drugs Controller General of India (DCGI) has also granted emergency use authorisation (EUA) to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule 28 days apart for those aged above 12 years.

 Covid-19: Green signal to Covaxin for kids aged 6-12
Covid-19: Green signal to Covaxin for kids aged 6-12

Covaxin, one of the main vaccines administered to adults, is currently being administered to children in the age group of 15-18 years.

High Immune Response To Covid Variants In Breakthrough Cases After 2 Covaxin Jabs: ICMR Study
High Immune Response To Covid Variants In Breakthrough Cases After 2 Covaxin Jabs: ICMR Study

The findings of the study, conducted in February this year after isolating the Omicron variant, have been published in the Journal of Infection on April 5.

Bharat Biotech UpgraBharat Biotech Upgrading Facilitding Facilities As WHO Suspends Covaxin Supplies
Bharat Biotech Upgrading Facilities As WHO Suspends Covaxin Supplies

The WHO said in a statement late on on Saturday that the Covaxin suspension was in response to the outcomes of its post EUL (emergency use authorisation) inspection, held between March 14-22, and the need to conduct process and facility upgrades to address recently identified GMP (good manufacturing practice) deficiencies.

WHO
WHO Suspends Covaxin Supply To UN Agencies

Bharat Biotech on April 1 announced the temporary slowing down of production of its covid-19 vaccine Covaxin across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.

Bharat Biotech's Covaxin
Bharat Biotech Announces Slowing Down Of Covaxin Production

Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced the temporary slowing down of its Covid vaccine Covaxin's production across its manufacturing facilities.

Omicron Wave: USA Vs India Vaccination Chart
Covaxin, Covishield Shoots Down Omicron Wave In India, USA Waits For Omicron-Specific Vaccine

With cases remaining on the higher side, both in hospitalisation and mortalities, USA will soon launch Omicron-specific vaccine in March

Covaxin
Covaxin To Be Evaluated As Covid Vaccine In US

Covaxin is India's indigenous Covid-19 vaccine manufactured by Bharat Biotech, which has been developed in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV)

Covishield, Covaxin
Regular Market Approval Granted For Covishield, Covaxin For Use In Adult Population

The DCGI approval came after the SEC on COVID-19 of the CDSCO on January 19 recommended granting regular market approval to the SII's Covishield and Bharat Biotech's Covaxin for use in adult population subject to certain conditions.

Bharat Biotech's Krishna Ella
Couple Behind India's Indigenous Covid Vaccine Gets Padma Bhushan

Dr Krishna Ella and Suchitra Ella, the couple behind Bharat Biotech, which developed India's first indigenous vaccine for Covid-19, have been awarded Padma Bhushan, the third highest civilian award in the country.

Covid vaccine
Covishield, Covaxin Cleared For Regular Market Approval

Hyderabad-based Bharat Biotech had submitted complete information on chemistry, manufacturing, and controls, along with the pre-clinical and clinical data while seeking regular market authorisation for Covaxin.

COVID Vaccine
Total of 158.74 Cr COVID-19 Vaccine Doses Administered; Over 3.7 Cr In 15-18 Age Group Get First Dose

The cumulative COVID-19 vaccine doses administered in the country have reached 158.74 crore so far, the Union Health Ministry said on Tuesday.

Study Shows Booster Dose Of Covaxin Has Neutralising Effect On Omicron, Delta Variants: Bharat Biotech
Study Shows Booster Dose Of Covaxin Has Neutralising Effect On Omicron, Delta Variants: Bharat Biotech

Citing the study results, Bharat Biotech noted that more than 90 per cent of all individuals boosted with Covaxin showed neutralising antibodies.

BOOSTER WORKING
COVAXIN Booster Dose Data Shows Promising Results

COVAXIN Booster Dose Data Shows Promising Results

Video Icon
Will Omicron Duck Covishield And Covaxin?
Glasgow Centre For Virus Research Finds Big: Omicron Can Duck Covishield, Covaxin!

As per the findings, Indicative studies have shown that 3 doses of Wuhan-strain based vaccines may provide only partial protection from infection with this variant

Covid Vaccination of children in India
Teenagers COVAXINated: It’s ‘Victory’ Against Covid-19

Adding another feather in the cap of India’s vaccination drive, the much-awaited inoculation of teenagers in the 15-18 years age group kicked off across the country on Monday (January 3). About 42 lakh children in the age group were inoculated on the first day of Covid vaccination.

Photos
How India Is Vaccinating Teenagers Amid Omicron Spread
How India Is Vaccinating Teenagers Amid Omicron Spread

The vaccine used for inoculating children is Bharat Biotech's Covaxin, according to a set of new guidelines issued by the Union health ministry.

Covaxin For Children Proven To Be Safe In Paediatric Subjects In Study: Bharat Biotech
Covaxin For Children Proven To Be Safe In Paediatric Subjects In Study: Bharat Biotech

No serious adverse event was reported. 374 subjects reported either mild or moderate severity symptoms with 78.6 per cent getting resolved within one day.

Bharat Biotechs Covaxin
Covaxin only vaccine option for children in 15-18 years age group: Govt

According to new guidelines issued by the Union health ministry on Monday, the vaccine option against COVID-19 for children in the age group of 15-18 years, who will be inoculated from January 3, would be Covaxin only

Ensure Availability Of Covaxin If Mixed Match Policy For Booster Is Adopted: IMA
Ensure Availability Of Covaxin If Mixed Match Policy For Booster Is Adopted: IMA

On the ongoing RDA strike which has hit all the medical services in the national capital, the IMA said that the issue of expediting PG counselling is the need of the hour to increase manpower ahead of the looming third wave threat.

DGCI Nod To Covaxin For Use In Children Above 12 Years With Certain Conditions
DGCI Nod To Covaxin For Use In Children Above 12 Years With Certain Conditions

The DCGI gave its approval Friday, the source said.

Covaxin
Covaxin Shows 50% Effectiveness Against Symptomatic COVID-19 In Real-World Assessment: Lancet Study

The research was conducted during the peak of India's second wave of COVID-19 with high test positivity rates for both hospital employees and residents of Delhi, they said.

COVID Vaccine
Nepal, India to recognise Covid vax certification

An MoU was signed to recognise Covid-19 vaccine certification by India's Ambassador to Nepal Vinay Mohan Kwatra and the Himalayan nation's Health Secretary on Tuesday.

110 Countries Recognise India's Covishield, Covaxin: Source
110 Countries Recognise India's Covishield, Covaxin: Source

Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines -- Covaxin and Covishield -- are from India.

 Covaxin
Covaxin 77.8% Effective Against COVID-19: Lancet study

The phase 3 trial Efficacy and Safety Study involving 25,800 volunteers across 25 sites in India is India's largest ever clinical trial conducted for a Covid-19 vaccine.

Covaxin
UK To Add India's Covaxin To Approved List From November 22

Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.

Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids
Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids

Covaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.

Finally Approved!
Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Video Icon
Bharat Biotech's Covaxin
Bharat Biotech's Covaxin gets WHO's nod

The World Health Organisation (WHO) granted Emergency Use Listing approval to India's indigenously-developed Covid vaccine, Bharat Biotech's Covaxin on Wednesday.

Covaxin
CDSCO approves extension of Covaxin's shelf life to 12 months

India's drug regulator, the Central Drugs Standards Control Organisation (CDSCO) has approved the extension of shelf life of indigenously-developed Covid-19 vaccine Covaxin from nine to 12 months.

Covaxin
After Australia, 5 More Countries Recognise India's Covaxin

Five more countries on Monday recognised India's vaccine certificate, after Australia recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine

Covaxin
Australia Recognises India's Covaxin

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.

WHO Body Seeks More Clarification To Decide On Covaxin EUL
WHO Body Seeks More Clarification To Decide On Covaxin EUL

Hyderabad based Bharat Biotech is expected to submit the data by this weekend.

Bharat Biotech's Covaxin
WHO May Approve Bharat Biotech's Covaxin Within 24 Hours

The Hyderabad-based Bharat Biotech had applied to the WHO on April 19 for Covaxin's Emergency Use Listing

COVID-19 Vaccine
Don't Cast Doubt On Vaccination: SC Junks Plea Against Mass Vax Of Covishield, Covaxin

The top court told the petitioner's counsel that it finds no error with the high court decision in the matter, and it will not entertain the petition.

WHO To Meet Next Week To Consider Emergency Use Listing Of India's Covaxin
WHO To Meet Next Week To Consider Emergency Use Listing Of India's Covaxin

Bharat Biotech recently said it has submitted all data pertaining to Covaxin to the WHO for the EUL and is awaiting feedback from the global health watchdog.

Covaxin Approved
Finally, Covaxin Approved For Children In 2-18 Yrs Age Group, DCGI Gives Nod

The Drugs and Comptroller General of India (DCGI) has given a go-ahead to Bharat Biotech's Covaxin for vaccination of children in the 2-18 years age group.

Video Icon
 Covaxin
Covaxin Approved For Children In 2-18 Age Group

The Subject Expert Committee (SEC) has given the necessary approval for the administration of the anti-Covid vaccine to children.

Covaxin or Covishield?
No Difference In Covaxin & Covishield Antibodies: Top Odisha Health Offical

There is no difference in antibodies produced by Covaxin and Covishield vaccines against the Covid-19 virus. This information was shared by Odisha Health Services Director Bijay Mohapatra on Monday (Sept 27).

Video Icon
COVAXIN
Covaxin May Get WHO Approval By Month-End, Says NITI Aayog

Covaxin may soon receive Emergency Use Listing by the World Health Organisation (WHO), eventually enabling its recipients to travel abroad without mandatory quarantine, NITI Aayog's Member, Health, V.K. Paul said on Wednesday.

scrollToTop